| Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells Y Yang, SY Neo, Z Chen, W Cui, Y Chen, M Guo, Y Wang, H Xu, A Kurzay, ... The Journal of Clinical Investigation 130 (10), 5508-5522, 2020 | 64 | 2020 |
| Tumor characterization in breast cancer identifies immune-relevant gene signatures associated with prognosis J Li, C Liu, Y Chen, C Gao, M Wang, X Ma, W Zhang, J Zhuang, Y Yao, ... Frontiers in Genetics 10, 1119, 2019 | 59 | 2019 |
| LncROR promotes bladder cancer cell proliferation, migration, and epithelial-mesenchymal transition Y Chen, Y Peng, Z Xu, B Ge, X Xiang, T Zhang, L Gao, H Shi, C Wang, ... Cellular physiology and biochemistry 41 (6), 2399-2410, 2017 | 50 | 2017 |
| TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma Y Zhang, Y Chen, C Yang, N Seger, AC Hesla, P Tsagkozis, O Larsson, ... Modern Pathology 34 (11), 2020-2027, 2021 | 26 | 2021 |
| Interleukin‐33 is a novel immunosuppressor that protects cancer cells from TIL killing by a macrophage‐mediated shedding mechanism J Wu, Z Chen, SL Wickström, J Gao, X He, X Jing, J Wu, Q Du, M Yang, ... Advanced Science 8 (21), 2101029, 2021 | 24 | 2021 |
| Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8 JO Paulsson, N Rafati, S DiLorenzo, Y Chen, F Haglund, J Zedenius, ... The Journal of Clinical Endocrinology & Metabolism 106 (11), 3265-3282, 2021 | 23 | 2021 |
| ARHGAP25 inhibits pancreatic adenocarcinoma growth by suppressing glycolysis via AKT/mTOR pathway WK Huang, Y Chen, H Su, TY Chen, J Gao, Y Liu, CN Yeh, S Li International journal of biological sciences 17 (7), 1808, 2021 | 21 | 2021 |
| Telomerase promoter mutations and copy number alterations in solitary fibrous tumours Y Lin, N Seger, P Tsagkozis, AC Hesla, M Ghaderi, Y Chen, M Ehnman, ... Journal of Clinical Pathology 71 (9), 832-839, 2018 | 17 | 2018 |
| Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy X Jing, J Han, J Zhang, Y Chen, J Yuan, J Wang, S Neo, S Li, X Yu, J Wu International journal of biological sciences 17 (14), 3968, 2021 | 16 | 2021 |
| hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality Y Lin, N Seger, Y Chen, AC Hesla, J Wejde, M Ghaderi, P Tsagkozis, ... Modern Pathology 31 (12), 1834-1841, 2018 | 16 | 2018 |
| Follicular helper T-cell-based classification of endometrial cancer promotes precise checkpoint immunotherapy and provides prognostic stratification Y Chen, S You, J Li, Y Zhang, G Kokaraki, E Epstein, J Carlson, ... Frontiers in Immunology 12, 788959, 2022 | 13 | 2022 |
| Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers C Yang, Y Zhang, Y Chen, F Ragaller, M Liu, S Corvigno, H Dahlstrand, ... PLoS One 15 (7), e0236291, 2020 | 12 | 2020 |
| Identification of an RNA-binding-protein-based prognostic model for Ewing sarcoma Y Chen, H Su, Y Su, Y Zhang, Y Lin, F Haglund Cancers 13 (15), 3736, 2021 | 9 | 2021 |
| Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells Z Chen, Y Yang, SY Neo, H Shi, Y Chen, AK Wagner, K Larsson, L Tong, ... EMBO reports 22 (3), e51329, 2021 | 9 | 2021 |
| Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer X Huang, C Chen, Y Xu, L Shen, Y Chen, H Su Bioengineered 12 (1), 2688-2701, 2021 | 8 | 2021 |
| Integrated analysis of copy number variation, microsatellite instability, and tumor mutation burden identifies an 11-gene signature predicting survival in breast cancer X Jin, J Yan, C Chen, Y Chen, WK Huang Frontiers in Cell and Developmental Biology 9, 721505, 2021 | 7 | 2021 |
| Transcriptome profiling of Ewing sarcomas–treatment resistance pathways and IGF‐dependency Y Chen, AC Hesla, Y Lin, M Ghaderi, M Liu, C Yang, Y Zhang, ... Molecular Oncology 14 (5), 1101-1117, 2020 | 7 | 2020 |
| Immunological classification of pancreatic carcinomas to identify immune index and provide a strategy for patient stratification Y Chen, D Chen, Q Wang, Y Xu, X Huang, F Haglund, H Su Frontiers in Immunology 12, 719105, 2022 | 6 | 2022 |
| Evaluation of PD-L1 expression in undifferentiated pleomorphic sarcomas, liposarcomas and chondrosarcomas Y Zhang, Y Chen, A Papakonstantinou, P Tsagkozis, C Linder-Stragliotto, ... Biomolecules 12 (2), 292, 2022 | 5 | 2022 |
| Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer Y Xu, D Chen, L Shen, X Huang, Y Chen, H Su Frontiers in Genetics 12, 736158, 2021 | 4 | 2021 |
